Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1960 1
1962 5
1964 2
1965 4
1966 3
1967 1
1968 2
1969 2
1970 3
1971 1
1972 1
1973 3
1974 4
1975 4
1976 5
1977 7
1978 11
1979 19
1980 6
1981 11
1982 17
1983 15
1984 13
1985 15
1986 20
1987 21
1988 20
1989 24
1990 25
1991 28
1992 26
1993 41
1994 30
1995 45
1996 42
1997 33
1998 40
1999 59
2000 49
2001 51
2002 50
2003 59
2004 62
2005 79
2006 99
2007 121
2008 144
2009 155
2010 159
2011 186
2012 206
2013 229
2014 232
2015 234
2016 212
2017 206
2018 199
2019 214
2020 247
2021 293
2022 259
2023 285
2024 286
2025 249

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,648 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Spesolimab for Generalized Pustular Psoriasis.
Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, Navarini AA, Zheng M, Xu J, Turki H, Anadkat MJ, Rajeswari S, Hua H, Vulcu SD, Hall D, Tetzlaff K, Thoma C, Lebwohl MG; Effisayil 1 Trial Investigators. Bachelez H, et al. Among authors: tsai tf. N Engl J Med. 2021 Dec 23;385(26):2431-2440. doi: 10.1056/NEJMoa2111563. N Engl J Med. 2021. PMID: 34936739 Free article. Clinical Trial.
Secukinumab in plaque psoriasis--results of two phase 3 trials.
Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, Rivas E, Tsai TF, Wasel N, Tyring S, Salko T, Hampele I, Notter M, Karpov A, Helou S, Papavassilis C; ERASURE Study Group; FIXTURE Study Group. Langley RG, et al. Among authors: tsai tf. N Engl J Med. 2014 Jul 24;371(4):326-38. doi: 10.1056/NEJMoa1314258. Epub 2014 Jul 9. N Engl J Med. 2014. PMID: 25007392 Free article. Clinical Trial.
Proteome-wide structural changes measured with limited proteolysis-mass spectrometry: an advanced protocol for high-throughput applications.
Malinovska L, Cappelletti V, Kohler D, Piazza I, Tsai TH, Pepelnjak M, Stalder P, Dörig C, Sesterhenn F, Elsässer F, Kralickova L, Beaton N, Reiter L, de Souza N, Vitek O, Picotti P. Malinovska L, et al. Among authors: tsai th. Nat Protoc. 2023 Mar;18(3):659-682. doi: 10.1038/s41596-022-00771-x. Epub 2022 Dec 16. Nat Protoc. 2023. PMID: 36526727 Review.
Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial.
Morita A, Strober B, Burden AD, Choon SE, Anadkat MJ, Marrakchi S, Tsai TF, Gordon KB, Thaçi D, Zheng M, Hu N, Haeufel T, Thoma C, Lebwohl MG. Morita A, et al. Among authors: tsai tf. Lancet. 2023 Oct 28;402(10412):1541-1551. doi: 10.1016/S0140-6736(23)01378-8. Epub 2023 Sep 19. Lancet. 2023. PMID: 37738999 Clinical Trial.
Man With Dyspnea.
Lee JY, Lin JW, Tsai TY. Lee JY, et al. Among authors: tsai ty. Ann Emerg Med. 2023 Oct;82(4):e157-e158. doi: 10.1016/j.annemergmed.2023.04.007. Ann Emerg Med. 2023. PMID: 37739757 No abstract available.
Long-term outcomes following bioresorbable vascular scaffolds.
Miyashita K, Ninomiya K, Tobe A, Masuda S, Kotoku N, Kageyama S, Revaiah PC, Tsai TY, Wang B, Garg S, Serruys PW, Onuma Y. Miyashita K, et al. Among authors: tsai ty. Expert Rev Cardiovasc Ther. 2024 Aug;22(8):391-407. doi: 10.1080/14779072.2024.2375340. Epub 2024 Jul 30. Expert Rev Cardiovasc Ther. 2024. PMID: 39049728 Review.
15-Gene Expression Profile and PRAME as Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1).
Harbour JW, Correa ZM, Schefler AC, Mruthyunjaya P, Materin MA, Aaberg TA Jr, Skalet AH, Reichstein DA, Weis E, Kim IK, Fuller TS, Demirci H, Piggott KD, Williams BK, Shildkrot E, Capone A Jr, Oliver SC, Walter SD, Mason J 3rd, Char DH, Altaweel M, Wells JR, Duker JS, Hovland PG, Gombos DS, Tsai T, Javid C, Marr BP, Gao A, Decatur CL, Dollar JJ, Kurtenbach S, Zhang S. Harbour JW, et al. Among authors: tsai t. J Clin Oncol. 2024 Oct;42(28):3319-3329. doi: 10.1200/JCO.24.00447. Epub 2024 Jul 25. J Clin Oncol. 2024. PMID: 39052972 Free PMC article.
Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2).
Yosipovitch G, Kim BS, Kwatra SG, Mollanazar NK, Ständer S, Satoh T, Mendes-Bastos P, Tsai TF, Laws E, Nivens MC, Maloney J, Shi G, Bansal A, Dubost-Brama A. Yosipovitch G, et al. Among authors: tsai tf. JAAD Int. 2024 Apr 10;16:163-174. doi: 10.1016/j.jdin.2024.03.025. eCollection 2024 Sep. JAAD Int. 2024. PMID: 39006917 Free PMC article.
4,648 results